Tower Research Capital LLC (Trc) Pure Tech Health PLC Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Pure Tech Health PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 73 shares of PRTC stock, worth $1,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73
Previous 137
46.72%
Holding current value
$1,486
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRTC
# of Institutions
7Shares Held
322KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC302KShares$6.15 Million0.37% of portfolio
-
Pentwater Capital Management LP Naples, FL16.2KShares$329,6890.01% of portfolio
-
Morgan Stanley New York, NY2.83KShares$57,5570.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX700Shares$14,2520.0% of portfolio
-
Ubs Group Ag351Shares$7,1460.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $568M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...